PFA ‐100‐measured aspirin resistance is the predominant risk factor for hospitalized cardiovascular events in aspirin‐treated patients: A 5‐year cohort study

Journal of Clinical Pharmacy and Therapeutics,Volume 43, Issue 2, Page 249-255, April 2018.

Source: Journal of Clinical Pharmacy and Therapeutics - October 21, 2017 Category: Drugs & Pharmacology Source Type: research